Cencora, Inc. COR

306.92 (2.95) (0.95%) as of 25 Sep
Market cap
$59.1B
P/E
22.7×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Cencora, Inc. (COR) P/S ratio

As of 25 September 2026, Cencora, Inc. (COR) trades at a P/S ratio of 0.2×. Over the past ten years it has ranged from 0.1× (March 2020) to 0.2× (November 2025); the current reading is higher than 87% of that period. That is below the Medical Distribution industry median of 0.2× and below the Healthcare sector median of 3.8×.

P/S ratio, daily

Annual

Period P/S ratio Change
FY2025 0.2× 24.01%
FY2024 0.2× 9.91%
FY2023 0.1× 17.01%
FY2022 0.1× 2.87%
FY2021 0.1× 9.95%
FY2020 0.1× 8.52%
FY2019 0.1× (20.02%)
FY2018 0.1× 1.35%
FY2017 0.1× 1.80%
FY2016 0.1× (23.32%)

Quarterly

Period P/S ratio Change
Jun 2026 0.2× (11.67%)
Mar 2026 0.2× (7.70%)
Dec 2025 0.2× 6.84%
Sep 2025 0.2× 2.72%
42 more quarters

Against its own ten years

Low 0.1× High 0.2×
Ten-year median 0.1×
Current reading's percentile 87

P/S ratio against peers

Company P/S ratio
YI 111, Inc. Sponsored ADR compare 0.0×
ACH Accendra Health, Inc. compare 0.0×
COR Cencora, Inc. 0.2×
CAH Cardinal Health, Inc. compare 0.2×
MCK McKesson Corporation compare 0.3×
COSM Cosmos Health Inc. compare 0.3×
HSIC Henry Schein, Inc. compare 0.7×
AHG Akso Health Group Sponsored ADR compare 0.9×
FOCL FocalTherics compare 2.2×
Medical Distribution industry median 0.2×
Healthcare sector median 3.8×
Market median 2.0×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on COR